The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program

被引：2
作者：
Silberstein, S. [1 ]
Dodick, D. W. [2 ]
DeGryse, R. E. [3 ]
Lipton, R. [4 ]
Turkel, C. C. [3 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Mayo Clin Arizona, Phoenix, AZ USA
[3] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2013年 / 14卷
关键词：
Migraine; Treatment Cycle; Chronic Migraine; Migraine Patient; Responder Rate;
D O I：
10.1186/1129-2377-14-S1-P200
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
[41]   Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study [J].
Navarro-Perez, Maria Pilar ;
Gonzalez-Quintanilla, Vicente ;
Munoz-Vendrell, Albert ;
Madrigal, Elisabet ;
Alpuente, Alicia ;
Latorre, German ;
Molina, Francis ;
Monzon, Maria Jose ;
Medrano, Vicente ;
Garcia-Azorin, David ;
Gonzalez-Oria, Carmen ;
Gago-Veiga, Ana ;
Velasco, Fernando ;
Beltran, Isabel ;
Morollon, Noemi ;
Viguera, Javier ;
Casas-Limon, Javier ;
Rodriguez-Vico, Jaime ;
Cuadrado, Elisa ;
Irimia, Pablo ;
Iglesias, Fernando ;
Guerrero-Peral, angel Luis ;
Belvis, Robert ;
Pozo-Rosich, Patricia ;
Pascual, Julio ;
Santos-Lasaosa, Sonia .
FRONTIERS IN NEUROLOGY, 2024, 15
[42]   P045. OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse [J].
Simona Guerzoni ;
Maria Michela Cainazzo ;
Luigi Alberto Pini .
The Journal of Headache and Pain, 2015, 16
[43]   Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK [J].
Khalil, M. ;
Zafar, H. ;
Quarshie, V. ;
Ahmed, F. .
JOURNAL OF HEADACHE AND PAIN, 2014, 15
[44]   Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine [J].
Bratbak, Daniel Fossum ;
Nordgard, Stale ;
Stovner, Lars Jacob ;
Linde, Mattias ;
Dodick, David W. ;
Aschehoug, Irina ;
Folvik, Mari ;
Tronvik, Erling .
CEPHALALGIA, 2017, 37 (04) :356-364
[45]   Real Life Data on OnabotulinumtoxinA for Treatment of Chronic Migraine in Pediatric Age [J].
Papetti, Laura ;
Frattale, Ilaria ;
Ursitti, Fabiana ;
Sforza, Giorgia ;
Monte, Gabriele ;
Ferilli, Michela Ada Noris ;
Tarantino, Samuela ;
Proietti Checchi, Martina ;
Valeriani, Massimiliano .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
[46]   ONABOTULINUMTOXINA IS WELL TOLERATED IN CHRONIC MIGRAINE PATIENTS TAKING ORAL PREVENTIVE MEDICATIONS: LONG-TERM COMPEL ANALYSIS BY TREATMENT CYCLE [J].
Winner, Paul K. ;
Blumenfeld, Andrew M. ;
Eross, Eric J. ;
Orejudos, Amelia ;
Adams, Aubrey Manack ;
Brin, Mitchell F. .
TOXICON, 2018, 156 :S114-S114
[47]   A Qualitative Study to Explore Patient Perspectives of Prophylactic Treatment with OnabotulinumtoxinA for Chronic Migraine [J].
Wilderman, Igor ;
Tallarigo, Deborah ;
Pugacheva-Zingerman, Olga .
PAIN AND THERAPY, 2021, 10 (02) :1523-1536
[48]   A Qualitative Study to Explore Patient Perspectives of Prophylactic Treatment with OnabotulinumtoxinA for Chronic Migraine [J].
Igor Wilderman ;
Deborah Tallarigo ;
Olga Pugacheva-Zingerman .
Pain and Therapy, 2021, 10 :1523-1536
[49]   Onabotulinumtoxin-A treatment in Greek patients with chronic migraine [J].
Vikelis, Michail ;
Argyriou, Andreas A. ;
Dermitzakis, Emmanouil V. ;
Spingos, Konstantinos C. ;
Mitsikostas, Dimos D. .
JOURNAL OF HEADACHE AND PAIN, 2016, 17
[50]   EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK [J].
M Khalil ;
H Zafar ;
V Quarshie ;
F Ahmed .
The Journal of Headache and Pain, 2014, 15
12345